These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 19149534)
1. PDGF-D signaling: a novel target in cancer therapy. Wang Z; Kong D; Li Y; Sarkar FH Curr Drug Targets; 2009 Jan; 10(1):38-41. PubMed ID: 19149534 [TBL] [Abstract][Full Text] [Related]
3. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation. Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905 [TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor-D modulates extracellular matrix homeostasis and remodeling through TIMP-1 induction and attenuation of MMP-2 and MMP-9 gelatinase activities. Borkham-Kamphorst E; Alexi P; Tihaa L; Haas U; Weiskirchen R Biochem Biophys Res Commun; 2015 Feb; 457(3):307-13. PubMed ID: 25576870 [TBL] [Abstract][Full Text] [Related]
5. PDGF receptors as targets in tumor treatment. Ostman A; Heldin CH Adv Cancer Res; 2007; 97():247-74. PubMed ID: 17419949 [TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosis. Martin IV; Borkham-Kamphorst E; Zok S; van Roeyen CR; Eriksson U; Boor P; Hittatiya K; Fischer HP; Wasmuth HE; Weiskirchen R; Eitner F; Floege J; Ostendorf T Am J Pathol; 2013 Jan; 182(1):107-17. PubMed ID: 23141925 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling. Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465 [TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells. Kong D; Banerjee S; Huang W; Li Y; Wang Z; Kim HR; Sarkar FH Cancer Res; 2008 Mar; 68(6):1927-34. PubMed ID: 18339874 [TBL] [Abstract][Full Text] [Related]
9. Emerging roles of PDGF-D signaling pathway in tumor development and progression. Wang Z; Ahmad A; Li Y; Kong D; Azmi AS; Banerjee S; Sarkar FH Biochim Biophys Acta; 2010 Aug; 1806(1):122-30. PubMed ID: 20434526 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide. Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796 [TBL] [Abstract][Full Text] [Related]
11. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway. Zhang H; Sun JD; Yan LJ; Zhao XP Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice. Lev DC; Kim SJ; Onn A; Stone V; Nam DH; Yazici S; Fidler IJ; Price JE Clin Cancer Res; 2005 Jan; 11(1):306-14. PubMed ID: 15671560 [TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor (PDGF) and glial tumorigenesis. Shih AH; Holland EC Cancer Lett; 2006 Feb; 232(2):139-47. PubMed ID: 16139423 [TBL] [Abstract][Full Text] [Related]
14. Cediranib inhibits both the intraosseous growth of PDGF D-positive prostate cancer cells and the associated bone reaction. Najy AJ; Jung YS; Won JJ; Conley-LaComb MK; Saliganan A; Kim CJ; Heath E; Cher ML; Bonfil RD; Kim HR Prostate; 2012 Sep; 72(12):1328-38. PubMed ID: 22213159 [TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers. Appiah-Kubi K; Wang Y; Qian H; Wu M; Yao X; Wu Y; Chen Y Tumour Biol; 2016 Aug; 37(8):10053-66. PubMed ID: 27193823 [TBL] [Abstract][Full Text] [Related]
16. Regulation of platelet-derived growth factor signaling by activated p21Ras. Stice LL; Vaziri C; Faller DV Front Biosci; 1999 Jan; 4():D72-86. PubMed ID: 9889183 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet-derived growth factor C and their receptors additionally increases doxorubicin effects in triple-negative breast cancer cells. Kim S; You D; Jeong Y; Yoon SY; Kim SA; Lee JE Eur J Pharmacol; 2021 Mar; 895():173868. PubMed ID: 33460613 [TBL] [Abstract][Full Text] [Related]